Anne Hege Aamodt Congratulates Gisle Berg Helland on PhD Defense About Stroke Outcome MRI and ML Prediction
Anne Hege Aamodt, Member Board of Directors at European Stroke Organisation, shared on LinkedIn:
”Warm congratulations to Gisle Berg Helland on the successful defence of your PhD thesis, ‘Long-Term Ischemic Stroke Outcome Prediction Using MRI and Machine Learning.’
This is an impressive and highly relevant body of work at the intersection of stroke medicine, advanced MRI, and machine learning.
Outstanding contributions by the opponents Johanna Ospel and Teresa Ullberg, and by Geir Ringstad as Chair of the adjudication committee.
Many thanks to the committee for a thorough evaluation and a stimulating scientific discussion.
Special thanks to Ole Morten Rønning for excellent leadership of the defence, and extra congratulations to Einar August Høgestøl, the principal supervisor, for outstanding mentorship throughout the project.
It has been a true pleasure to contribute as co-supervisor together with Hanne Flinstad Harbo and Guri Hagberg and to collaborate closely with such a dedicated, insightful, and collegial candidate.
Congratulations again on this well-deserved milestone, Gisle — wishing you every success in your continued career!”
More winner stories featured in Hemostasis Today.
-
Aug 21, 2026, 12:34Kellie Machlus: Animal Models Driving Progress in Thrombosis Research
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care
-
Aug 21, 2026, 10:10Pete Stibbs: The Evolving Landscape of VTE Management